Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Clinical trial NCT01065025 · COMPLETED

Trial details

NCT number: NCT01065025
Sponsor: 4SC AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced and Incurable Solid Tumors Malignant Lymphomas

Start date: 2010-01-01
Primary completion: 2015-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.